|
|
Volumn 66, Issue , 2012, Pages 109-115
|
|
Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms
|
|
Author keywords
Imatinib Mesylate; Related substance; Stability indicating; UPLC; Validation
|
|
Indexed keywords
IMATINIB;
ACCURACY;
ANALYTIC METHOD;
ARTICLE;
CHEMICAL COMPOSITION;
CONTROLLED STUDY;
CORRELATION COEFFICIENT;
DENSITY GRADIENT;
DRUG DEGRADATION;
DRUG DETERMINATION;
DRUG DOSAGE FORM;
DRUG FORMULATION;
DRUG PURITY;
DRUG SOLUBILITY;
DRUG STABILITY;
FLOW RATE;
HYDROLYSIS;
LIMIT OF DETECTION;
LIMIT OF QUANTITATION;
MAXIMUM PLASMA CONCENTRATION;
OXIDATIVE STRESS;
PHOTOLYSIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
REVERSED PHASE ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;
SENSITIVITY AND SPECIFICITY;
SPIKE WAVE;
TEMPERATURE STRESS;
ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;
ANTINEOPLASTIC AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DRUG CONTAMINATION;
DRUG STABILITY;
GUIDELINES AS TOPIC;
HYDROLYSIS;
LIMIT OF DETECTION;
OXIDATION-REDUCTION;
PIPERAZINES;
PYRIMIDINES;
REPRODUCIBILITY OF RESULTS;
TEMPERATURE;
|
|
EID: 84861221759
PISSN: 07317085
EISSN: 1873264X
Source Type: Journal
DOI: 10.1016/j.jpba.2012.03.022 Document Type: Article |
|
Times cited : (28)
|
|
References (11)
|
